Breast cancer
Open
Phase 3
This trial is looking at pumitamig with chemotherapy for a type of breast cancer called triple negative breast cancer.
It is for people with that:
has come back and cannot be removed by surgery
has spread to another part of the body or
has both of the above
You pronounce pumitamig as puh-mih--tah-mig.
Recruitment start: 23 February 2026
Recruitment end: 28 February 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Judy King
BioNTech SE
Bristol Myers Squibb
Last reviewed: 25 Feb 2026
CRUK internal database number: 20144